Savaria (TSE:SIS) Stock Price Expected to Rise, TD Securities Analyst Says

Savaria (TSE:SIS) had its price objective upped by stock analysts at TD Securities from C$27.00 to C$31.00 in a note issued to investors on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. TD Securities’ target price indicates a potential upside of 21.47% from the stock’s previous close.

Other analysts have also issued research reports about the stock. Stifel Nicolaus raised their target price on shares of Savaria from C$26.00 to C$28.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Scotiabank boosted their price target on Savaria from C$25.00 to C$26.00 in a report on Monday, November 10th. Finally, National Bank Financial increased their price target on Savaria from C$26.00 to C$30.00 in a research note on Monday, December 22nd. Seven investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Savaria presently has a consensus rating of “Buy” and an average price target of C$30.93.

Savaria Price Performance

TSE:SIS opened at C$25.52 on Thursday. Savaria has a 12-month low of C$14.97 and a 12-month high of C$26.42. The firm has a market cap of C$1.83 billion, a price-to-earnings ratio of 29.33, a price-to-earnings-growth ratio of 42.72 and a beta of 1.14. The company’s 50-day moving average is C$24.64 and its two-hundred day moving average is C$22.52. The company has a current ratio of 1.61, a quick ratio of 0.91 and a debt-to-equity ratio of 8.27.

Savaria (TSE:SIS) last issued its quarterly earnings results on Wednesday, March 4th. The company reported C$0.37 EPS for the quarter. The business had revenue of C$241.78 million during the quarter. Savaria had a net margin of 7.53% and a return on equity of 11.10%. Research analysts expect that Savaria will post 1.2048518 EPS for the current year.

Key Savaria News

Here are the key news stories impacting Savaria this week:

• Positive Sentiment: Multiple brokerages raised price targets and upgraded ratings this morning (ATB Cormark to C$32, Raymond James to C$32, National Bank to C$30.50, Scotiabank to C$30, Desjardins to C$32, Stifel and TD also higher). These raises signal stronger analyst confidence and imply double‑digit upside from current levels. Analyst Rating Roundup
• Positive Sentiment: Savaria reported record 2025 results and stronger margins, with Q4 revenue of C$241.8M and EPS C$0.37 — results the company says position it for a new growth phase around its Savaria One strategy. This fundamental momentum underpins the analyst upgrades. Record 2025 Results
• Positive Sentiment: Coverage pieces note Savaria “entering a new growth phase” after completion of Savaria One and record Q4, reinforcing the narrative for higher future growth and margin improvement. Growth Phase Article
• Neutral Sentiment: The shares briefly hit a 12‑month high following the analyst activity and results, attracting attention from retail and institutional traders. 12‑Month High Coverage
• Neutral Sentiment: Management’s earnings release and conference call are available for review (detailed Q4 release and call transcript), useful for investors who want to assess guidance and cadence of margin improvement. Press Release / Transcript
• Negative Sentiment: Despite the positive newsflow, the stock is lower — likely reflecting short‑term profit‑taking after a run to a 52‑week high, elevated trading volume, and valuation concerns (current reported P/E ~29 and very high PEG). Those factors can pressure the share price even amid upgrades. Market Data / Valuation

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.